Spherix has been tracking the C3G market for over four years in both the U.S. and Europe. The studies have provided meaningful insights into physician perceptions of unmet needs and expectations for ...

Removing zelnecirnon means the biotech’s sole remaining clinical-stage asset is tivumecirnon, a phase 2 oncology med being ...

Checkpoint Therapeutics' cosibelimab shows strong efficacy in treating cSCC. Learn why CKPT stock could see significant gains ...

PK Study Successfully Demonstrates that Fingerprint Sweat Provides Reliable Sample for Drug Detection FDA 510(k) Clearance ...

The CDC recommends a single dose of any FDA-approved respiratory syncytial virus (RSV) vaccine for all adults ages 75 years ...

Today's health news includes understanding Plan B's efficacy for people with higher BMIs, disparities in infant mortality, ...

Former host of the "Rush Limbaugh Show" James Golden, aka Bo Snerdley, discusses why he believes President-elect Donald Trump's decision to allow Robert F. Kennedy Jr. to “go wild” on health is ...

It’s another big day for Mesoblast Ltd (ASX: MSB) shares. Here’s why the ASX biotech stock is making news on Friday.

Doctors have been fairly quick to jump on the biologics train: According to Spherix, 96% of dermatologists reported using ...

The US Food and Drug Administration (FDA) has proposed an order to ban a popular ingredient in cold and flu medicines as it is seemingly not as effective as other methods. Oral phenylephrine is often ...

Belite Bio, Inc. ( NASDAQ: BLTE) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Tom Lin - Chairman and Chief Executive Officer Hendrik Scholl - Chief Medical Officer Nathan Mata - Chief ...

House races will still be counted through the weekend, as the GOP nears gaining control of the chamber. What Trump's could ...